Semaglutide shows promise in improving kidney function
A study suggests that semaglutide, the active ingredient in Ozempic, may help improve chronic kidney disease. Researchers found that the drug repaired blood vessels, reduced inflammation and improved kidney function in patients.
The findings add to the growing body of evidence about the potential health effects of semaglutide beyond its primary role in diabetes treatment. They do not by themselves establish that the drug can reverse kidney disease or replace established treatments, but the results point to a possible approach for addressing several of the underlying mechanisms involved in chronic kidney disease.